Vinpocetine is a clinically used synthetic vincamine derivative with a diverse pharmacological profile that includes action at several ion channels, principally "generic" populations of sodium channels that give rise to tetrodotoxin-sensitive conductances. A number of cell types are known to express tetrodotoxin-resistant (TTXr) sodium conductances, the molecular bases of which have remained elusive until recently. One such TTXr channel, termed Na V 1.8, is of particular interest because of its prominent and selective expression in peripheral afferent nerves. The effects of vinpocetine on TTXr channels specifically, are unknown. We have assessed the effects of the drug on cloned rat Na V 1.8 channels expressed in a dorsal root ganglion-derived cell line, ND7/23. Vinpocetine produced a concentration-and state-dependent inhibition of Na V 1.8 sodium channel activity. Voltage-clamp experiments revealed an ϳ3-fold increase in vinpocetine potency when whole-cell Na V 1.8 conductances were elicited from relatively depolarized potentials (Ϫ35 mV; IC 50 ϭ 3.5 M) compared with hyperpolarized holding potentials (Ϫ90 mV; IC 50 ϭ 10.4 M). Vinpocetine also produced an ϳ22 mV leftward shift in the voltage dependence of Na V 1.8 channel inactivation but did not affect the voltage range of channel activation. These properties are reminiscent of several other known sodium channel blockers and suggested that vinpocetine may exhibit frequency-dependent block. Accordingly, tonic block of Na V 1.8 channels by vinpocetine (3 M) increased proportionally with increasing depolarizing commands over the frequency range 0.1 to 1Hz. In summary, the present data demonstrate that vinpocetine is capable of blocking Na V 1.8 sodium channel activity and suggest a potential additional utility in various sensory abnormalities arising from abnormal peripheral nerve activity.
potency when whole-cell Na V 1.8 conductances were elicited from relatively depolarized potentials (Ϫ35 mV; IC 50 ϭ 3.5 M) compared with hyperpolarized holding potentials (Ϫ90 mV; IC 50 ϭ 10.4 M). Vinpocetine also produced an ϳ22 mV leftward shift in the voltage dependence of Na V 1.8 channel inactivation but did not affect the voltage range of channel activation. These properties are reminiscent of several other known sodium channel blockers and suggested that vinpocetine may exhibit frequency-dependent block. Accordingly, tonic block of Na V 1.8 channels by vinpocetine (3 M) increased proportionally with increasing depolarizing commands over the frequency range 0.1 to 1Hz. In summary, the present data demonstrate that vinpocetine is capable of blocking Na V 1.8 sodium channel activity and suggest a potential additional utility in various sensory abnormalities arising from abnormal peripheral nerve activity. Fig. 1) is a synthetic ethyl ester of the Vinca minor alkaloid apovincamine. A therapeutic formulation of vinpocetine, marketed under the proprietary name Cavinton has been used for more than 20 years in certain European countries and Japan as a cerebroprotective agent to reduce brain damage resulting from an ischemic infarct. The vincamine derivative, in common with many other plant-derived alkaloids, has a diverse pharmacological profile that includes phosphodiesterase inhibition, antioxidant properties, and an action at several ion channels (Bonoczk et al., 2000) . This somewhat promiscuous pharmacology has led to the justifiable classification of vinpocetine as a "nootropic", an aptly vague terminology given the lack of a clear mechanism of action.
Vinpocetine (
Despite the somewhat nonselective pharmacological profile, vinpocetine is claimed to be remarkably devoid of major side effects at clinically used dosages (Anonymous, 2002) . A number of studies have indicated, clearly, that vinpocetine achieves good brain exposure after systemic administration (Bonoczk et al., 2002; Gulyas et al., 2002) , and it is reasonable to assume that all of the above-mentioned actions may contribute to a therapeutic neuroprotective effect. The significance of the ion channel blocking effect of vinpocetine, particularly in respect to a sodium channel action, is supported by an anticonvulsant action in rodent seizure models (Schmidt, 1990) and from a comparative study using the established anticonvulsant drug phenytoin (Molnar and Erdo, 1995) . In addition to their clinical utility in the prevention of epileptiform seizures, anticonvulsants have found favor as a therapeutic approach to the management of certain pain states (Hunter and Loughhead, 1999; Dickenson et al., 2002) . There is mounting evidence (Hunter and Loughhead, 1999; Devor, 2001) to support a fundamental role for ectopic, epileptiform-like burst firing in peripheral nerves as a substrate for paroxysmal pains often described as "stabbing" or "electric-shock-like." Peripheral nerve axons express a mixed complement of sodium channel isoforms, one of which is a TTX-insensitive conductance mediated by Na V 1.8 (Hunter and Loughhead, 1999) . Although there is an ongoing debate over the relevant roles of various sodium channel activities in generating and sustaining chronic pain states, several stud-ies have indicated a prominent role for Na V 1.8 (Lai et al., 2000; Lai et al., 2002; Gold et al., 2003) . This study was designed to address the effects of vinpocetine on recombinant rat Na V 1.8 sodium channels expressed in a clonal cell line (ND7/23, derived from a dorsal root ganglion progenitor; Wood et al., 1990) , the data suggest a potential additional utility of the drug as an antinociceptive for use in neuropathic pain states.
Materials and Methods
Cloning and Expression of Na V 1.8 Sodium Channels in the ND7/23 Cell Line. Total RNA was isolated from rat dorsal root ganglia with RNA STAT-60 (Iso-Tex Diagnostics, Friendswood, TX). Random primed cDNA was reverse transcribed from 3 g of total RNA using SuperScript II RT (Invitrogen, Carlsbad, CA). Full-length polymerase chain reaction primers were designed based on the published rat Na V 1.8 (PN3) sequence U53833 (Sangameswaran et al., 1996) . The oligonucleotide sequences were as follows: 5Ј-ATGGAGCTCCCCTTT-GCGTCC and 5Ј-TCACTGAGGTCCAGGGCTGTT. Clones were sequence verified on an ABI3700 DNA sequencer with Big Dye Terminators version 2.0 (Applied Biosystems, Foster City, CA). The full-length coding sequence was inserted into the retroviral expression vector pMX for cloning.
For all whole-cell voltage-clamp experiments, a transient expression strategy was adopted that involved the cotransfection of rNa V 1.8 and green fluorescent protein (GFP) cDNAs, the latter was used as a marker gene to identify successfully transfected cells within a given population. ND7/23 cells were bulk cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum and 1% penicillin and 1% streptomycin. Transfections were performed weekly, cells were seeded into six-well culture plates at a density of 500 K/well and allowed 24 h to attach. A transfection mixture (100 l) containing FuGENE-6 (3 ml in 100 ml of serum-free DMEM; Invitrogen) and cDNA vectors (pcDNA3.1) containing coding sequences for GFP (0.5 g) and rNa V 1.8 (0.5 g), was added to each well. After 24-h incubation, the cells were resuspended in fresh DMEM and seeded, at a density of 50 K, on poly-L-lysine-coated coverslips for subsequent electrophysiological recordings.
Whole-Cell Voltage-Clamp Recordings. All whole-cell patchclamp recordings were carried out 48 to 72 h post-transfection; experiments were conducted at room temperature (19 -21°C). At the time of the experiment, an individual coverslip was removed from the culture plate and placed into a perfusion chamber mounted on the stage of an inverted phase-contrast microscope equipped with fluorescence optics. The cells were continuously perfused with a salt solution of the following composition: 129 mM NaCl, 3.2 5 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 10 mM HEPES, 11 mM D-glucose, and 20 mM tetraethylammonium-Cl, pH 7.4, 345 mOsM. Conventional whole-cell voltage-clamp electrophysiology was used to record voltage-activated currents; patch electrodes contained a solution of the following composition: 120 mM CsF, 10 mM NaCl, 10 mM HEPES, 11 mM EGTA, 10 mM tetraethylammonium-Cl, 1 mM CaCl 2 , and 1 mM MgCl 2 , pH 7.3, 325 mOsM. Cells were viewed briefly using a fluorescence microscope (fluorescein isothiocyanate filter set) and were selected on the basis of their relative fluorescence intensity. In all experiments, membrane potential was held at Ϫ90 mV between voltage command protocols. Drugs were applied by bath perfusion. Data were acquired online (sampling frequency 10 kHz, filtered at 2 kHz) using an Axopatch 200B amplifier and pCLAMP 8.0 software (Axon instruments, Inc., Foster City, CA). Series resistance (80%) and capacitance currents were electronically compensated.
Results
Characterization of Sodium Channel Conductances in Wild-Type and Transfected ND7/23 Cells. Nontransfected (i.e., wt) ND7/23 cells express a prominent sodium conductance ( Fig. 2A ; Table 1 ) that activates rapidly upon depolarization and is highly sensitive to TTX (IC 50 ϭ 3 nM). The molecular identity of the channel(s) responsible for the wt TTX-sensitive (TTXs) conductance is unknown but it is presumed that this is likely to arise from the activity of a mixed population of sodium channels. Regardless, the wt conductance was almost completely abolished by the perfusion of 300 nM TTX ( Fig. 2A) , the remaining sodium current under these conditions represented only 1.2% of the peak current recorded prior to TTX perfusion ( Table 1 ), indicating that ND7/23 cells do not constitutively express any appreciable TTX-resistant (TTXr) sodium channel isoforms. Transfection of rNa V 1.8 into this background (successful in approximately 85% of GFP-fluorescent cells; Table 1 ) introduced a prominent conductance that persisted in the presence of 30 M TTX (Fig. 2B ), a 100-fold excess of that required to completely suppress wt currents. By definition, the residual current is TTXr and must be considered to be due to the functional expression of the recombinant rNa V 1.8 protein.
The amplitude of the TTXr currents varied considerably between sampled cells but was usually several hundred picoAmps (see Table 1 for a representative data set). Transfection 
Fig. 2.
Macroscopic sodium currents recorded from wt and rNa V 1.8-transfected ND7/23 cells. A, typical rapidly activating and inactivating sodium current (black trace) elicited in a wt ND7/23 cell by a 50-ms voltage step from Ϫ90 to 10 mV. The current was completely abolished by the addition of TTX (300 nM) to the perfusate (gray trace). B, sodium currents recorded from a transfected ND7/23 cell. The larger of the three superimposed currents (black trace, solid line) represents total sodium current evoked by the same voltage step as in A. TTX (300 nM) was then added to the perfusate resulting, in this case, an incomplete (ϳ50%) reduction in current amplitude (dotted line). Perfusion of a 10-fold higher concentration of TTX (30 M) produced a small additional decrement in the conductance (gray trace) confirming the extreme resistance of rNa V 1.8 to the toxin. Scale bar, 2.5 nA and 25 ms, applies to both A and B.
Vinpocetine Block of Na V 1.8 Sodium Channels of GFP alone did not seem to change the phenotype of the ND7/23 cells, either morphologically or electrophysiologically and these control experiments found no evidence of a TTXr current induced by GFP transfection (Table 1 ). All subsequent experiments were performed in the continuous presence of 300 nM TTX to effectively isolate the conductance attributed to rNa V 1.8. Characterization of the rNa V 1.8 current under these conditions revealed a kinetic profile that was clearly distinct from that attributed to wt channels but very reminiscent of previously published data for rNa V 1.8. Although resistant to TTX, rNa V 1.8 currents were susceptible to very high concentrations of the toxin (ϳ23% inhibition at 30 M, n ϭ 6, comparable with data obtained by Akopian et al., 1996) , the fact that we never observed similar TTXr currents in wt cells strongly suggests that the TTXr conductance was, indeed, sodium channel-mediated.
Effect of Vinpocetine on rNa V 1.8 Activation. Voltagecurrent relationships were established for rNa V 1.8 channels by measuring peak current amplitude at various destination command voltages from a holding voltage of Ϫ90 mV. Perfusion of vinpocetine (30 M) reduced maximal current amplitude (command potential, 10 mV) by approximately 50% (Fig.  3A) . A plot of the corresponding fractional conductance (G/ G max ) elicited at each command voltage (Fig. 3B ) revealed a negligible effect of vinpocetine on the voltage dependence of rNa V 1.8 activation (V 0.5 control ϭ 1.0 Ϯ 0.6 mV; V 0.5 vinpocetine ϭ Ϫ1.4 Ϯ 0.9 mV).
Effect of Vinpocetine on rNa V 1.8 Inactivation. In common with all other voltage-gated sodium channels, the number of rNa V 1.8 channels available for activation is dependent upon the resting membrane potential. Proportionally fewer channels are available for activation as the resting membrane potential is moved progressively more depolarized, due to the accumulation of channels in an inactivated, nonconducting state. The extent to which this phenomenon occurs is a complex function of both time and voltage parameters. Experimentally, this relationship can be examined, at least empirically, and quantified by imposing constant duration prepulses to sequentially depolarized potentials and then stepping to a common destination voltage (Fig. 4A) . A plot of prepulse potential versus normalized peak current amplitude yielded a typical steady-state inactivation relationship from which the half-inactivation voltage (V 0.5,inact ) was determined by curve fitting (Boltzman function). Consistent with previously published data (Sangameswaran et al., 1996) , rNa V 1.8 channels were found to have a relatively positive V 0.5,inact value that was moved ϳ22 mV in the hyperpolarizing direction (V 0.5,inact control ϭ Ϫ34.1 Ϯ 0.7 mV, n ϭ 8; V 0.5,inact vinpocetine ϭ Ϫ56.4 Ϯ 1.0 mV, n ϭ 8) by vinpocetine (30 M; Fig. 4B ).
State-Dependent Inhibition of Sodium Currents by
Vinpocetine. Preliminary experiments revealed that the potency of vinpocetine was dependent upon the membrane holding potential even when the destination command voltage was held constant. Thus, vinpocetine (10 M) produced a greater attenuation (ϳ90%) of available current elicited by a step command to 10 mV from a holding potential of Ϫ35 mV (corresponding to the V 0.5,inact for rNa V 1.8) (Fig. 5B ) compared with similar experiments performed from a more hyperpolarized holding potential of Ϫ90 mV (ϳ50% attenuation) (Fig. 5A ). This is a characteristic feature of "local anesthetic" sodium channel blockers (e.g., lidocaine and mexilitine) and suggested a higher affinity interaction for vinpocetine with the inactivated channel state. More detailed experiments revealed the concentration-inhibition curves for vinpocetine sodium channel block were left-shifted when holding potential was clamped at the relatively more depolarized Ϫ35 mV compared with Ϫ90 mV (Fig. 5C ). Vinpocetine was approximately 3-fold more potent (IC 50(Ϫ90 mV) ϭ 10.4 M; IC 50(Ϫ35 mV) ϭ 3.5 M) when currents were evoked from a holding potential of Ϫ35 mV.
Although we do not know the identity of the sodium channels responsible for the background TTXs conductance in the ND7/23 cell line, we considered it of interest to determine the influence of vinpocetine on this conductance. Experiments Fig. 3 . A, current-voltage plots for rNa V 1.8 macroscopic currents obtained in the absence and presence of vinpocetine. Whole-cell currents were evoked using a series of depolarizing steps from a holding potential of Ϫ90 mV, in 10-mV increments, to a final command potential of 80 mV. Mean data (Ϯ S.E.M., n ϭ 7) are shown for control (F) and vinpocetine (30 M; f) conditions. Vinpocetine reduced peak current amplitude but did not change in the shape of the current-voltage relationship. B, activation curves (mean Ϯ S.E.M., n ϭ 7) for rNa V 1.8 conductance in the absence (F) and presence (f) of vinpocetine (30 M). Vinpocetine produced a marginal, although significant (P Ͻ 0.05) modification of activation gating only over the negative activation-voltage range. Downloaded from similar to those described above were conducted using the wt cell line, and revealed a similar potency of vinpocetine and a similar state dependence of the drug on the wt TTXs current. Thus, vinpocetine was ϳ6-fold more potent at blocking currents elicited from the half-inactivation voltage for TTXs currents (IC 50(Ϫ65 mV) ϭ 3.8 M) than from the full-activation voltage (IC 50(Ϫ120 mV) ϭ 24.5 M).
Vinpocetine Block of rNa V 1.8 Sodium Channels Is Frequency-Dependent. Voltage-gated sodium channels require a period of membrane repolarization to reprime after depolarization-induced activation. In the case of particular native TTXr channels in dorsal root ganglion neurons, repriming has been previously reported to be rapid (Elliott and Elliott, 1993; Rush et al., 1998) . We have found a similar property for rNa V 1.8 in ND7/23 cells (Dong et al., 2001) ; in other words, these channels seem to require only brief periods of membrane repolarization to reestablish their availability and, hence, can sustain relatively high-frequency duty cycles. Repriming rates are usually studied using a series of paired pulse experiments in which two depolarizing pulses (designed to achieve full activation) are separated by a series of variable but precise interpulse intervals. A comparison of peak current amplitude elicited by the second pulse with respect to the first provides an index of channel availability at the specified interpulse interval. However, similar information can be derived from frequency-response relationships of the sort depicted in Fig. 7 . A comparison of the fractional availability of rNa V 1.8 channels is provided by the amplitude of each second pulse in the series in relation to the initial amplitude, the pulse interval being the reciprocal of the stimulation frequency. These experiments revealed approximately 80% of the rNa V 1.8 channel population to be available for activation by the second stimulus at the shortest interval (50 ms) tested (Fig. 6) . However, the same pulse interval in the presence of vinpocetine (30 M) resulted in a significant reduction in channel availability (ϳ20%), suggesting that the majority of channels had failed to reprime during the 50-ms interval (Fig. 6) . As the interval between successive paired pulses was increased, progressively more channels recovered, despite the presence of vinpocetine, although an interval of ϳ10 s was required to ensure a degree of repriming (80%) comparable with that seen in the absence of the drug (Fig. 6) .
A corollary to the slowing of repriming by vinpocetine is that the drug should promote an accumulation of blocked channels during periods of high-frequency stimulation. Figure 7 provides some indication of accumulation, particularly at higher stimulation frequencies. The control experiments (Fig. 7A) reveal that there is no loss of channel availability at 0.1-Hz stimulation, whereas at 10 Hz approximately 60% of the total channel population remains available at the end of a 25-sequence pulse train. The data obtained from similar experiments repeated in the presence of vinpocetine (10 M) revealed clear evidence of frequency-dependent channel block by the drug (Fig. 7B) . At the lowest stimulation frequency (0.1Hz) approximately 20% of the available channels were rapidly taken out of commission by vinpocetine, and there is a small but noticeable accumulation of blocked channels throughout the remaining stimuli. Increasing the stimulation frequency revealed additional, rapidly equilibrating channel blockade that seemed to saturate at frequencies above 1 Hz (Fig. 7B) . The frequency dependence is better appreciated by considering the extra fractional block elicited at each stimulation frequency (Fig. 7C) . Analyzing the data in this way revealed clear evidence of frequency-dependent block by vinpocetine up to stimulation frequencies of 1 Hz, approximately 50% additional TTXr conductance is eliminated by the drug at this frequency.
Discussion
Molecular cloning has led to the identification of nine functionally characterized sodium channel transcripts (Goldin, 2000) , although the possibility of hitherto unidentified splice variants may add to this complexity. The majority of sodium channels are highly sensitive to channel block by TTX, yet two family members, Na V 1.8 and Na V 1.9, stand out as being distinct in their relative resistance to TTX, whereas a third family member, Na V 1.5, occupies an intermediate TTX sensitivity (Goldin, 2000) . Several previous studies have shown vinpocetine to be a sodium channel blocker, these studies have used rat cultured cerebrocortical neurons (Molnar and Erdo, 1995) or guinea pig cortical synaptosomes (Tretter and Adam-Vizi, 1998) . Although the precise details of the sodium channel isoforms expressed in these preparations are un- Fig. 4 . A, standard steady-state inactivation voltage command protocol (insert) and the corresponding superimposed macroscopic rNa V 1.8 currents. Holding potential was Ϫ90 mV, prepulse command potential range was Ϫ120 to 10 mV (10-mV increments, 100-ms duration), and test command potential was 10 mV. The current traces have been cropped to the initial 50 ms for clarity; scale bar, 50 pA, 10 ms. B, steady-state inactivation curves (mean Ϯ S.E.M., n ϭ 8) for macroscopic rNa V 1.8 currents before (F) and during (f) vinpocetine (30 M) using the protocol described in A. Vinpocetine produced a significant hyperpolarizing shift (⌬V 0.5, inact ϭ 22.3 mV) of the steady-state inactivation curve.
Vinpocetine Block of Na V 1.8 Sodium Channels 501 at ASPET Journals on April 20, 2017 jpet.aspetjournals.org known, it is reasonable to assume that the sodium conductances were likely to be predominantly, if not exclusively, mediated by TTX-sensitive channels. Whole-cell voltageclamp analysis of the effects of vinpocetine on sodium currents recorded from cerebrocortical neurons (Molnar and Erdo, 1995) revealed a potency (IC 50 ϭ 44 M) comparable with that of the established sodium channel blocker phenytoin (IC 50 ϭ 50 M). A subsequent study revealed a similar blocking effect of vinpocetine on sodium currents recorded from rat cardiac ventricular myocytes (Wei et al., 1997) . Although, once again, the precise molecular identity of the conductance was not established, this study is of interest because cardiac myocytes are known to express the TTXinsensitive Na V 1.5 channel isoform. Our data suggest that vinpocetine is appreciably (Ͼ10-fold) more potent (IC 50(Ϫ65 mV) ϭ 3.8 M) at blocking TTXs than Molnar and Erdo (1995) found in their studies. The difference may be due, at least in part, to methodological differences, although the latter studies used a similar holding potential (Ϫ60 mV), a key factor governing apparent potency. We consider a more likely explanation may be biological (channel isoform) differences.
The present study was undertaken as a result of the continued clinical use of vinpocetine and, specifically, sought to explore the action of the alkaloid derivative on a molecularly identified sodium channel isoform, rNa V 1.8. This sodium channel is of particular interest in view of its selective expression pattern. In the rat, the protein is only found in a subpopulation of peripheral sensory afferent nerves (Akopian et al., 1996; Novakovic et al., 1998) . Moreover, Na V 1.8 displays gating characteristics that are different to the other sodium family members and, as mentioned previously, is pharmacologically novel in terms of its resistance to site I toxins. The possibility exists, therefore, for additional pharmacological divergence between Na V 1.8 and other sodium channel isoforms although, at least to date, there have been no reports of small molecules that are capable of discriminating between the various members of the sodium channel family.
Expression analysis, using the whole-cell voltage-clamp approach, revealed the clonal ND7/23 cell line to be a suitable heterologous host cell line capable of sustaining robust rNa V 1.8 expression that could be studied, in isolation, by the simple addition of TTX to the extracellular perfusate (Dong et al., 2001) .
Vinpocetine had negligible effect on the voltage characteristics of rNa V 1.8 activation but produced a clear hyperpolarizing shift in the inactivation curve. This profile is consistent with vinpocetine binding selectively to the inactivated state of the channel, the functional consequence of this effect would be to limit the dynamic range of membrane potentials over which rNa V 1.8 would likely operate. These data suggested that the binding of vinpocetine was state-dependent, and this was confirmed by determining the potency of the drug at different resting membrane potentials. Although these experiments revealed vinpocetine to be more effective during sustained depolarized states the difference in affinity is marginal (ϳ3-fold) compared with other known sodium channel blockers. For example, similar but more marked differences in state-dependent affinity have been described previously for other sodium channel blockers, notably the 5 . A, tonic block of macroscopic rNa V 1.8 currents by vinpocetine. Discrete whole-cell currents were evoked at 30-s intervals by 50-ms command pulses to 10 mV from a holding potential of Ϫ90 mV (left trace) or Ϫ35 mV (approximately half inactivation voltage, right trace) before (black lines) and after equilibration (gray lines) with vinpocetine (10 M). The superimposed traces represent the final control current and first currents recorded in vinpocetine, the attenuation of current amplitude (gray trace) represents tonic block by the drug. Note the significantly greater inhibition (ϳ85% versus ϳ40%) of the current by the drug under depolarized conditions. Scale bar, 500 pA, 20 ms. B, vinpocetine concentration-response curves for tonic and inactivated state block (mean Ϯ S.E.M., n ϭ 8) obtained from transfected ND7/23 cells subjected to the protocols described in A and B. Vinpocetine exhibits higher affinity (ϳ3-fold) for the inactivated state of the rNa V 1.8 channel (f) compared with tonic block from the resting state (F).
local anesthetics (e.g., lidocaine) (Balser et al., 1996) and certain anticonvulsants (phenytoin, carbamazepine, and lamotrigine; Catterall, 1999) , observations that are consistent with the concept of the modulated receptor model (Hille, 1992) . It must be considered likely that vinpocetine acts in a similar manner and that the higher apparent affinity of the drug for the inactivated state reflects a slower dissociation rate from that state. Also consistent with this mechanism is the phenomenon of use dependence. Repetitive and brief membrane depolarizations force sodium channels to cycle through activation, inactivation, and repriming states. The ability of a given channel to follow such activity at high cycle rates is, primarily, a function of the rate of recovery from inactivation, the repriming rate. Native TTXr channels have been shown previously to display rapid repriming kinetics. The use-dependent block exerted by vinpocetine is likely to reflect the slow rate of dissociation of the drug from blocked channels during repolarization, effectively slowing the repriming rate. At low-frequency stimulations (e.g., 0.1 Hz) the drug off-rate is presumably fast enough to ensure recovery of the majority of the available channels before the next depolarizing pulse in the cycle. As the stimulation frequency is increased, the interpulse interval decreases accordingly and the result is manifest as a proportional increase in the drugbound channels at the onset of the subsequent depolarization. The frequency-dependent component of vinpocetine's effects on rNa V 1.8, although clear, is modest compared with that observed for other sodium channel blockers studied under the same conditions (X. W. Dong, unpublished observations) . A previous study (Wei et al., 1997) that examined the effect of vinpocetine (40 M) on cardiac myocyte sodium channels found no evidence of use-dependent block. This apparent contradiction may represent a genuine difference attributed to different channel isoforms or may reflect different experimental conditions. The manifestation of use-dependent block is a complex interaction between channel and drug kinetics, a simple change in drug concentration can result in a profoundly different use-dependent profile.
We describe vinpocetine as a potent (IC 50 ϭ ϳ3 M) rNa V 1.8 channel blocker, although it is more meaningful to consider whether the affinity of the drug for the Na V 1.8 channel is relevant in relation to the plasma levels attained in typical clinical settings. The reported C max values, achieved in human subjects after a 10-mg dose of vinpocetine, are around 30 to 60 ng ml Ϫ1 (Vereczkey et al., 1979 ; showing the fractional recovery of rNa V 1.8 sodium current as a function of time interval between two successive voltage pulses. The holding potential was Ϫ90 mV and voltage commands to 10 mV were delivered at varying intervals, the amplitude of the current response to the second pulse was expressed as a function of that elicited to the first to derive the fractional recovery of channels from the inactivated state (i.e., repriming). The control data (open columns) show that rNa V 1.8 channels were capable of following instantaneous stimulation frequencies up to 10 Hz (50-ms interval) with little decrement (ϳ80% recovery), shorter intervals were not examined. Vinpocetine (30 M) produced a dramatic reduction in repriming rate (filled columns) such that intervals up to almost 10 s were required to achieve the same ϳ80% recovery between successive pulses. Fig. 7 . A, frequency-response relationships for macroscopic rNa V 1.8 currents recorded in the absence (A, control) and presence (B) of vinpocetine (10 M). Whole-cell currents were evoked by step depolarization commands (holding potential, Ϫ90 mV; destination potential, 10 mV; pulse duration, 50 ms) delivered at the following frequencies: 0.1 Hz (f), 0.3Hz (F), 1 Hz (OE), 3 Hz (), and 10 Hz (ࡗ). Peak-current amplitudes (mean Ϯ S.E.M., n ϭ 6 -8) were normalized to that of the first response at each frequency and are shown plotted against pulse number. The additional fractional block elicited at each stimulation frequency is shown in C to better illustrate the use-dependent sodium channel block by vinpocetine.
Vinpocetine Block of Na V 1.8 Sodium Channels
503
at ASPET Journals on April 20, 2017 jpet.aspetjournals.org Lohmann et al., 1992) , corresponding to around 100 to 200 nM. However, the drug as a very high volume of distribution and readily partitions into the brain (Gulyas et al., 1999) and, presumably, other fatty tissues that are likely to include the peripheral nerves. Hence, true tissue exposure levels may be somewhat higher than the circulating plasma level and, in any event, are within the range that might be expected to produce some attenuation of sodium channel function. It is somewhat harder to predict, with respect to therapeutic efficacy, the relative contribution of sodium channel block compared with the many other pharmacological actions of the drug. However, similar potencies have been claimed for an antioxidant action (Horvath et al., 2002) and phosphodiesterase E-1 inhibition (Chiu et al., 1988) , suggesting that sodium channel block may impart a significant contribution to overall efficacy (Bonoczk et al., 2000) . In summary, the present data demonstrate that vinpocetine is capable of blocking rNa V 1.8 sodium channels at concentrations that may be therapeutically relevant. The nature of these experiments reveal this to be a direct effect on the channel (probably the "local anesthetic" pharmacophore) and not secondary to an action on Ca 2ϩ or K ϩ channels, although an action at either of these additional targets could contribute to an overall effect on neuronal excitability. The continued clinical use of the drug in the neurotrauma arena and the absence of reported serious side effects may warrant expansion of vinpocetine's clinical utility to examine a potential benefit in the control of neuropathic pain (Lai et al., 2000) and bladder hyperreflexia (Yoshimura et al., 2002) conditions that have been linked to inappropriate Na V 1.8 sodium channel activity.
